| Tag | Content |
|---|
EnhancerAtlas ID | HS108-12732 |
Organism | Homo sapiens |
Tissue/cell | K562 |
Coordinate | chr14:103892720-103894720 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESR2 | MA0258.2 | chr14:103894216-103894231 | GGGTCTTTGTGACCT | - | 6.34 | | IRF1 | MA0050.2 | chr14:103893839-103893860 | AAAAAAAAAAAGAAACAAAAG | - | 6.21 | | RARA(var.2) | MA0730.1 | chr14:103894132-103894149 | AGGACAACCAGAGGTCA | + | 6.62 | | STAT1 | MA0137.3 | chr14:103893964-103893975 | TTTCTGGGAAA | + | 6.02 | | STAT3 | MA0144.2 | chr14:103893964-103893975 | TTTCTGGGAAA | + | 6.32 | | Stat4 | MA0518.1 | chr14:103893964-103893978 | TTTCTGGGAAAAGG | + | 6.15 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09869 | chr14:103891788-103893241 | CD14 | | SE_09869 | chr14:103893831-103896534 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr14 | 103893389 | 103893529 | | chr14 | 103893849 | 103894522 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH14I103427 | chr14 | 103892738 | 103893150 | | GH14I103426 | chr14 | 103893282 | 103895765 |
|
Enhancer Sequence | CAAAAAGTGT GAGAATGTTT GATGTAGAGA AACTCCAAGC TCATTCCCTG GACTTTGGCT 60
ATAGATGCTT TCTTCAGGGG TGGGTCTTCT GGGCCTGTGT CCTGCAGGAT GCCCAGTAGG 120
AAGCACAGCC TCTTTGATCT TATGGGGGTG GGCTCATTTG CTGTTTTGGA GCTCAGGTGC 180
AAAGCCGAGT TACTTGATAT TCCCTGGTCA TGGCAAAGCC TCTCTCCACT TTTCTTCCCT 240
TCTATTGTCA CTTCCATTCT TTTTCCATAG TCCATAGAAA TCATTTTTAC GTGACAGTGA 300
TGAGCTGACC AGAAGCTATA GAAGCTATAG TACTTCCTAT ATCCTAATGG GTTTTAAAAA 360
CACTGGCTGG GGCATACTCA CCCTTTCTGA ACAAAGGCTG CTAGGTGACC CTGCTGTTGC 420
CGCTCTGTAT ATTCACTTGG TTAGCCCACA GATTGGTTTG GACCTAATTC CCTTTCCTTC 480
TTTAACTGCC CAAAGGGCTT TTCTATTTAA AAAAAAAAAA AAAAAATTTT TAAAGTTTTC 540
AGATTCAATA CCCACCTATT TGTATGCTTA CCCATCCCAG AGTCAGCTAA ATTTAAAGTG 600
TCAGTAAATT GTAAAGAAAA GATTTGCTAC ATTGCATATG TTTTTAGAAG TGCTTTCTGT 660
GTATAATCTC TCTCTCTCTC TCTTTTTTTC TTGGTTTGGA GGAGACTTTC CCCTTGTCTA 720
TAAGTAACTT AAATATAAAA TGTTATAACA ATACGTTTAT TAGTTTGAAG CCCCAATTTT 780
CTTTTTTTTT TTTCTTTTAA GTGAAAACAA GTTTATAAAA GAAGTAAAGA AACAGGCCAG 840
GCGCTGTGGC TCACACGTGT AATCCTAGCA CATTGGGAGG CCGAGGCAGG TGGATCACCT 900
GGGGTCAGGA GTTCGAGACC AGCCTGGCCA ACATGGTGAA ACCCCATCTC TACTAAAAAT 960
ACAAAATTAG CCAGTCGTGG TGGTGCGCAC CTGTAATCCC AGCTACTCCA GAGGCTGAGG 1020
GAGTAGAAAC TATGAAAACT TGGGAGATGG AGGTTGCAAT GAGCCGAGAT CATGTCACTG 1080
CTCTCCAGCC TAGGCAACAG AGGGAGACTG TTTCAAAAAA AAAAAAAAAA GAAACAAAAG 1140
AATGGCTGCT CCATAGACAG AGCAGCAGTA TCAGCTGCTT GACTGAGTCT ACTTATAGTT 1200
ATTTCTTGAT TATATGCTAA ACAAGGGGTG AATTATTCAT GAGCTTTCTG GGAAAAGGGC 1260
AGAGATTTCC TGGAACTGAA GGTCCCTCCC CTTTTAGGGG ACTATTTAGG GTAACTTCCC 1320
AAGGTTGCCG TGGCATTTGT AAACTGTCAT GGTGGTGGTG GGAGTGTCTT TTAGCATGCT 1380
GATGCATTAT AATTAGCTTA TAATGAGCAG TGAGGACAAC CAGAGGTCAC TTTCATCGCC 1440
ATCTTGGTTT TGGTGGGTTT TGGCCTGCTT CTTTACCACA TCCTGTTCTA TCAGCAGGGT 1500
CTTTGTGACC TGTATCTTCT GCCAAGCTCC TCCTATCTCA CCCTGTGACT AAGAATGCCT 1560
GACTTCCTGG GAATGCAGCC CAGTAGGTCT CAGGCTTATT TTACCCAGCC CCTTTTCAAG 1620
ATGGAGTTGC TCTGGTTCAA ACACTTCTGA CATATTTCCC CCCTCCCTTT TACAGGGGGA 1680
CCCTTAATCC TTAAGAATTG TAGCGGGACA AAGATCATCT GTAACTTCTT CAAGCCAAAT 1740
AGGGGTGATG ATATTCCTGC CTATTAGGGT CTCTTGTATT TAGGGTAGGG AGAAGTTTAG 1800
TTAGAAAGCA TTGTTATAGA AGCCCTTATT TTCAGTTACA CAATTTTATA AAGTTACAAT 1860
TGCTTATTGT AACCAGCTGA GTTTTAGGTT TTGTGGTTTG TTGCTTGCTT GCTTGCTTGC 1920
TTCTTAATGC CATATATCTT GGCATTTATC AGTCCATAAT TACTAAATTC TTAAAATCCA 1980
TAAATATTTA TTATTCTTTC 2000
|
